Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Pan Jian Gang, Liu Mo, Yang Lu, Luo Runqi & Zhou Xing. (2015) Diabetes mellitus and the risk of prostate cancer: an update and cumulative meta-analysis. Endocrine Research 40:1, pages 54-61.
Read now
Read now
Carl W White, Jin Han Xie & Sabatino Ventura. (2013) Age-related changes in the innervation of the prostate gland. Organogenesis 9:3, pages 206-215.
Read now
Read now
Articles from other publishers (35)
Chih-Chung Lin, Ming-Fen Wu, Yen-Lin Chang, Wayne Huey-Herng Sheu & Wen-Shyong Liou. (2022) Glycemic control was associated with nonprostate cancer and overall mortalities in diabetic patients with prostate cancer. Journal of the Chinese Medical Association 85:3, pages 331-340.
Crossref
Crossref
Teemu J. Murtola, Ville JY Vihervuori, Jorma Lahtela, Kirsi Talala, Kimmo Taari, Teuvo LJ Tammela & Anssi Auvinen. (2018) Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer. British Journal of Cancer 118:9, pages 1248-1254.
Crossref
Crossref
Reza Rastmanesh, Jalal Hejazi, Francesco Marotta & Noboru Hara. (2014) Type 2 Diabetes: A Protective Factor for Prostate Cancer? An Overview of Proposed Mechanisms. Clinical Genitourinary Cancer 12:3, pages 143-148.
Crossref
Crossref
David Margel, David Urbach, Lorraine L. Lipscombe, Chaim M. Bell, Girish Kulkarni, Peter C. Austin & Neil Fleshner. (2013) Association Between Metformin Use and Risk of Prostate Cancer and Its Grade. JNCI: Journal of the National Cancer Institute 105:15, pages 1123-1131.
Crossref
Crossref
Hua Xu, Hao-wen Jiang, Guan-xiong Ding, Hu Zhang, Li-min Zhang, Shan-hua Mao & Qiang Ding. (2013) Diabetes mellitus and prostate cancer risk of different grade or stage: A systematic review and meta-analysis. Diabetes Research and Clinical Practice 99:3, pages 241-249.
Crossref
Crossref
Fan Zhang, Yuan Yang, Laura Skrip, Dayi Hu, Yang Wang, Chunguang Wong, Jingfu Qiu & Han Lei. (2012) Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case–control and 25 cohort studies. Acta Diabetologica 49:S1, pages 235-246.
Crossref
Crossref
R. Tewari, S. Rajender, S. M. Natu, D. Dalela, A. Goel, M. M. Goel & P. Tandon. (2012) Diet, Obesity, and Prostate Health: Are We Missing the Link?. Journal of Andrology 33:5, pages 763-776.
Crossref
Crossref
K A Moses, O A Utuama, M Goodman & M M Issa. (2011) The association of diabetes and positive prostate biopsy in a US veteran population. Prostate Cancer and Prostatic Diseases 15:1, pages 70-74.
Crossref
Crossref
X.-X. He, S.M. Tu, M.-H. Lee & S.-C. J. Yeung. (2011) Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients. Annals of Oncology 22:12, pages 2640-2645.
Crossref
Crossref
Daniel M. Moreira, Tiffany Anderson, Leah Gerber, Jean-Alfred Thomas, Lionel L. Bañez, Madeline G. McKeever, Cathrine Hoyo, Delores Grant, Jayakrishnan Jayachandran & Stephen J. Freedland. (2011) The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series. Cancer Causes & Control 22:7, pages 977-983.
Crossref
Crossref
Irina Mordukhovich, Paul L. Reiter, Danielle M. Backes, Leila Family, Lauren E. McCullough, Katie M. O’Brien, Hilda Razzaghi & Andrew F. Olshan. (2010) A review of African American-white differences in risk factors for cancer: prostate cancer. Cancer Causes & Control 22:3, pages 341-357.
Crossref
Crossref
Elizabeth A. Atchison, Gloria Gridley, J. Daniel Carreon, Michael F. Leitzmann & Katherine A. McGlynn. (2010) Risk of cancer in a large cohort of U.S. veterans with diabetes. International Journal of Cancer 128:3, pages 635-643.
Crossref
Crossref
Tamra E. Meyer, Eric Boerwinkle, Alanna C. Morrison, Kelly A. Volcik, Maureen Sanderson, Ann L. Coker, James S. Pankow & Aaron R. Folsom. (2010) Diabetes Genes and Prostate Cancer in the Atherosclerosis Risk in Communities Study. Cancer Epidemiology, Biomarkers & Prevention 19:2, pages 558-565.
Crossref
Crossref
Sheila Weinmann, Jean A. Shapiro, Benjamin A. Rybicki, Shelley M. Enger, Stephen K. Van Den Eeden, Kathryn E. Richert-Boe & Noel S. Weiss. (2009) Medical history, body size, and cigarette smoking in relation to fatal prostate cancer. Cancer Causes & Control 21:1, pages 117-125.
Crossref
Crossref
Sung Kyu Hong, Seung Tae Lee, Sung Soo Kim, Kyung Eun Min, Seok‐Soo Byun, Sung Yong Cho, Gheeyoung Choe & Sang Eun Lee. (2009) Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer. The Prostate 69:8, pages 820-826.
Crossref
Crossref
K. M. Waters, B. E. Henderson, D. O. Stram, P. Wan, L. N. Kolonel & C. A. Haiman. (2009) Association of Diabetes With Prostate Cancer Risk in the Multiethnic Cohort. American Journal of Epidemiology 169:8, pages 937-945.
Crossref
Crossref
Michael F. Leitzmann, Jiyoung Ahn, Demetrius Albanes, Ann W. Hsing, Arthur Schatzkin, Shih-Chen Chang, Wen-Yi Huang, Jocelyn M. Weiss, Kim N. Danforth, Robert L. GrubbIIIIII & Gerald L. Andriole. (2008) Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes & Control 19:10, pages 1267-1276.
Crossref
Crossref
Sandeep Dhindsa, Manish Upadhyay, Prabhakar Viswanathan, Susan Howard, Ajay Chaudhuri & Paresh Dandona. (2008) Relationship of Prostate -Specific Antigen to Age and Testosterone in Men With Type 2 Diabetes Mellitus. Endocrine Practice 14:8, pages 1000-1005.
Crossref
Crossref
T. J. Murtola, T. L. J. Tammela, J. Lahtela & A. Auvinen. (2008) Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study. American Journal of Epidemiology 168:8, pages 925-931.
Crossref
Crossref
Jeanne A. Darbinian, Assiamira M. Ferrara, Stephen K. Van Den Eeden, Charles P. QuesenberryJr.Jr., Bruce Fireman & Laurel A. Habel. (2008) Glycemic Status and Risk of Prostate Cancer. Cancer Epidemiology, Biomarkers & Prevention 17:3, pages 628-635.
Crossref
Crossref
Maria E Ramos-Nino, Charles D MacLean & Benjamin Littenberg. (2007) Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System. BMC Medicine 5:1.
Crossref
Crossref
Souad R. Sennoune & Raul Martinez-Zaguilan. (2007) Plasmalemmal vacuolar H+-ATPases in angiogenesis, diabetes and cancer. Journal of Bioenergetics and Biomembranes 39:5-6, pages 427-433.
Crossref
Crossref
Brook A. Calton, Shih Chen Chang, Margaret E. Wright, Victor Kipnis, Karla Lawson, Frances E. Thompson, Amy F. Subar, Traci Mouw, David S. Campbell, Paul Hurwitz, Albert Hollenbeck, Arthur Schatzkin & Michael F. Leitzmann. (2007) History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes & Control 18:5, pages 493-503.
Crossref
Crossref
Edward Giovannucci & Dominique Michaud. (2007) The Role of Obesity and Related Metabolic Disturbances in Cancers of the Colon, Prostate, and Pancreas. Gastroenterology 132:6, pages 2208-2225.
Crossref
Crossref
Lonneke V. van de Poll-Franse, Saskia Houterman, Maryska L.G. Janssen-Heijnen, Marcus W. Dercksen, Jan Willem W. Coebergh & Harm R. Haak. (2007) Less aggressive treatment and worse overall survival in cancer patients with diabetes: A large population based analysis. International Journal of Cancer 120:9, pages 1986-1992.
Crossref
Crossref
C M Velicer, S Dublin & E White. (2006) Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications. Prostate Cancer and Prostatic Diseases 10:1, pages 46-51.
Crossref
Crossref
Kiyonori Kuriki, Kaoru Hirose & Kazuo Tajima. (2007) Diabetes and cancer risk for all and specific sites among Japanese men and women. European Journal of Cancer Prevention 16:1, pages 83-89.
Crossref
Crossref
Jocelyn S. Kasper & Edward Giovannucci. (2006) A Meta-analysis of Diabetes Mellitus and the Risk of Prostate Cancer. Cancer Epidemiology, Biomarkers & Prevention 15:11, pages 2056-2062.
Crossref
Crossref
A. González-Pérez & L.A. García Rodríguez. (2005) Prostate Cancer Risk Among Men with Diabetes Mellitus (Spain). Cancer Causes & Control 16:9, pages 1055-1058.
Crossref
Crossref
A. Tavani, S. Gallus, M. Bertuzzi, L. Dal Maso, A. Zucchetto, E. Negri, S. Franceschi, V. Ramazzotti, M. Montella & C. La Vecchia. (2005) Diabetes Mellitus and the Risk of Prostate Cancer in Italy. European Urology 47:3, pages 313-317.
Crossref
Crossref
M. Ruiz-Ramos & A. Escolar Pujolar. (2005) La mortalidad por cáncer de próstata en andalucía: aportaciones al cribado poblacional. Actas Urológicas Españolas 29:1, pages 41-46.
Crossref
Crossref
David G. Bostwick, Harry B. Burke, Daniel Djakiew, Susan Euling, Shuk-mei Ho, Joseph Landolph, Howard Morrison, Babasaheb Sonawane, Tiffany Shifflett, David J. Waters & Barry Timms. (2004) Human prostate cancer risk factors. Cancer 101:S10, pages 2371-2490.
Crossref
Crossref
Nancy Lightfoot, Michael Conlon, Nancy Kreiger, Andrea Sass-Kortsak, James Purdham & Gerarda Darlington. (2004) Medical history, sexual, and maturational factors and prostate cancer risk. Annals of Epidemiology 14:9, pages 655-662.
Crossref
Crossref
A L Coker, M Sanderson, W Zheng & M K Fadden. (2004) Diabetes mellitus and prostate cancer risk among older men: population-based case–control study. British Journal of Cancer 90:11, pages 2171-2175.
Crossref
Crossref
E.David Crawford. (2003) Epidemiology of prostate cancer. Urology 62:6, pages 3-12.
Crossref
Crossref